Education
About Us
Working with TipRanks
Follow Us
NEUCA S.A. (PL:NEU)
:NEU
NEU Stock Chart & Stats
zł844.00
--
Market closed
zł844.00
--
Day’s Range― - ―
52-Week Rangezł636.00 - zł868.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.23K
Market Cap
zł3.84B
Enterprise Valuezł3.49B
Total Cash (Recent Filing)zł126.82M
Total Debt (Recent Filing)zł538.93M
Price to Earnings (P/E)24.9
Beta0.52
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.95%
Share Statistics
EPS (TTM)13.26
Shares Outstanding4,582,919
10 Day Avg. Volume1,049
30 Day Avg. Volume1,226
Financial Highlights & Ratios
PEG Ratio6.79
Price to Book (P/B)3.42
Price to Sales (P/S)0.31
P/FCF Ratio-131.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NEU FAQ
What was NEUCA S.A.’s price range in the past 12 months?
NEUCA S.A. lowest stock price was zł636.00 and its highest was zł868.00 in the past 12 months.
What is NEUCA S.A.’s market cap?
NEUCA S.A.’s market cap is zł3.84B.
When is NEUCA S.A.’s upcoming earnings report date?
NEUCA S.A.’s upcoming earnings report date is Mar 26, 2026 which is in 72 days.
How were NEUCA S.A.’s earnings last quarter?
NEUCA S.A. released its earnings results on Nov 20, 2025. The company reported zł13.256 earnings per share for the quarter, beating the consensus estimate of N/A by zł13.256.
Is NEUCA S.A. overvalued?
According to Wall Street analysts NEUCA S.A.’s price is currently Overvalued.
Does NEUCA S.A. pay dividends?
NEUCA S.A. pays a Annually dividend of zł16 which represents an annual dividend yield of 1.95%. See more information on NEUCA S.A. dividends here
What is NEUCA S.A.’s EPS estimate?
NEUCA S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NEUCA S.A. have?
NEUCA S.A. has 4,582,919 shares outstanding.
What happened to NEUCA S.A.’s price movement after its last earnings report?
NEUCA S.A. reported an EPS of zł13.256 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.827%.
Which hedge fund is a major shareholder of NEUCA S.A.?
Currently, no hedge funds are holding shares in PL:NEU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NEUCA S.A.
NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, telemedicine, agency, financial, road cargo transport, accounting and bookkeeping, software, hospital, and information technology and computer related services; and health, property, and other personal insurance products. In addition, it operates outpatient care clinics and medical stores. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.
Technical Analysis
Ryvu Therapeutics SA
―
Scope Fluidics SA
―
Voxel S.A.
―
Celon Pharma SA
―
Selvita SA
―